Align Technology, Inc. vs Abrdn Physical Platinum Shares ETF — how do they compare? Align Technology, Inc. trades at $179.9 (market cap $12.86B), while Abrdn Physical Platinum Shares ETF trades at $14.67. The key difference: Align Technology, Inc. is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | PPLT | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $207.19 | $25.23 |
52-Week Low | $124.88 | $11.78 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
PPLT trades at $14.77, up 1.03% with a bearish technical outlook as moving averages signal selling pressure. The ETF recently completed a 10-for-1 stock split effective May 2026, maintaining the same total value per shareholder. News coverage highlights platinum's underperformance relative to gold and silver, with Seeking Alpha downgrading the ETF to 'Hold' in May 2026 after substantial gains.
The outlook remains cautious as technical indicators show bearish momentum despite neutral oscillators. Platinum's lag in the precious metals rally presents potential catch-up opportunity, but current valuation lacks clear fundamental catalysts. Key risks include commodity price volatility and dependence on industrial demand cycles.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →